Cargando…
Determining the prevalence and severity of cancer cachexia in advanced non-small cell lung cancer and its relationship with chemotherapy outcomes
PURPOSE: Cancer cachexia (CC) is a syndrome characterised by an ongoing loss of skeletal muscle mass associated with reduced tolerance to treatment. This study explored the prevalence and severity of CC in advanced non-small cell lung cancer (NSCLC) patients and determined its relationship with chem...
Autores principales: | White, Rhys, Weekes, C. Elizabeth, Grant, Robert, Baldwin, Christine, Ahmed, Hafez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378112/ https://www.ncbi.nlm.nih.gov/pubmed/31916005 http://dx.doi.org/10.1007/s00520-019-05259-1 |
Ejemplares similares
-
Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia
por: Damrauer, Jeffrey S., et al.
Publicado: (2018) -
Incidence and frequency of cancer cachexia during chemotherapy for advanced pancreatic ductal adenocarcinoma
por: Mitsunaga, Shuichi, et al.
Publicado: (2020) -
Cancer cachexia as a determinant of efficacy of first-line pembrolizumab in patients with advanced non-small cell lung cancer
por: Fujii, Hironori, et al.
Publicado: (2022) -
Cachexia Index in Advanced Non-Small-Cell Lung Cancer Patients
por: Jafri, Syed Hasan Raza, et al.
Publicado: (2015) -
Lactate dehydrogenase: relationship with the diagnostic GLIM criterion for cachexia in patients with advanced cancer
por: McGovern, Josh, et al.
Publicado: (2022)